Paul A. Wender, Ph.D., Co-founder, Advisor

Professor Paul Wender is the Bergstrom Professor of Chemistry and, by courtesy, of Chemical and Systems Biology. He is a member of the US National Academy of Sciences and with his group has pioneered studies in synthesis, computer based drug design, chemistry, biology, medicinal chemistry, materials research, and drug delivery. He has served on numerous science advisory boards and for over 35 years as a consultant to medicinal and process chemistry groups in the pharmaceutical and biotech industries in the US and abroad.

Professor Wender’s pioneering research in synthesis – the physical and chemical manipulation of chemical reactions to create a new product – has led to the development of both new therapeutic agents and new methods for delivering drugs and probes into cells and tissues. The Wender Group has produced seminal contributions to the synthesis and use of the anti-cancer drug taxol, as well as phorbol, resiniferatoxin, and other molecules involved in medical research. Current research is directed at first-in-kind treatments for HIV/AIDS, resistant cancer, cognitive disorders such as Alzheimer’s disease, and infectious diseases as well as new approaches to vaccinations, protein therapy, cancer immunotherapy and gene editing based on mRNA.

Professor Wender has also been recognized for his teaching and dedication to the advancement of higher education.

For a more detailed bio and list of publications, please visit this site.